|
1
|
Leopold JA: Catheter-based therapies for
patients with medication-refractory pulmonary arterial
hypertension. Circ Cardiovasc Interv. 8:e0033322015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Olatunji LA, Seok YM, Igunnu A, Kang SH
and Kim IK: Combined oral contraceptive-induced hypertension is
accompanied by endothelial dysfunction and upregulated intrarenal
angiotensin II type 1 receptor gene expression. Naunyn
Schmiedebergs Arch Pharmacol. 389:1147–1157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng Y, Poon CC, Yan BP and Lau JY: Pulse
arrival time based cuff-less and 24-H wearable blood pressure
monitoring and its diagnostic value in hypertension. J Med Syst.
40:1952016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gerage AM, Bededetti TR, Ritti-Dias RM,
Dos Santos ACO, de Souza BCC and Almeida FA: Effectiveness of a
behavior change program on physical activity and eating habits in
patients with hypertension: A randomized controlled trial. J Phys
Act Health. 1–30. 2017.
|
|
5
|
Ambrozova G, Fidlerova T, Verescakova H,
Koudelka A, Rudolph TK, Woodcock SR, Freeman BA, Kubala L and
Pekarova M: Nitro-oleic acid inhibits vascular endothelial
inflammatory responses and the endothelial-mesenchymal transition.
Biochim Biophys Acta. 1860:2428–2437. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Souza PS, Gonçalves ED, Pedroso GS, Farias
HR, Junqueira SC, Marcon R, Tuon T, Cola M, Silveira PCL, Santos
AR, et al: Physical exercise attenuates experimental autoimmune
encephalomyelitis by inhibiting peripheral immune response and
blood-brain barrier disruption. Mol Neurobiol. 54:4723–4737. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Balduino Mendes AB, Giollo-Junior LT, de
Andrade DO, Gregório ML, Yugar-Toledo JC and Vilela-Martin JF: How
to investigate the vascular changes in resistant hypertension. Curr
Hypertens Rev. 12:139–147. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vaillancourt M, Ruffenach G, Meloche J and
Bonnet S: Adaptation and remodelling of the pulmonary circulation
in pulmonary hypertension. Can J Cardiol. 31:407–415. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jenkins D: Pulmonary endarterectomy: The
potentially curative treatment for patients with chronic
thromboembolic pulmonary hypertension. Eur Respir Rev. 24:263–271.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reynolds JA, Rosenberg AZ, Smith CK,
Sergeant JC, Rice GI, Briggs TA, Bruce IN and Kaplan MJ: Brief
Report: Vitamin D deficiency is associated with endothelial
dysfunction and increases type-1 interferon gene expression in a
murine model of systemic lupus erythematosus. Arthritis Rheumatol.
68:2929–2935. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Furumoto Y, Smith CK, Blanco L, Zhao W,
Brooks SR, Thacker SG, Abdalrahman Z, Sciumè G, Tsai WL, Trier AM,
et al: Tofacitinib ameliorates murine lupus and its associated
vascular dysfunction. Arthritis Rheumatol. 69:148–160. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Shi H, Luo J, Yi Y, Yao D, Zhang
X, Ma G and Loor JJ: MiR-145 regulates lipogenesis in goat mammary
cells via targeting INSIG1 and epigenetic regulation of
lipid-related genes. J Cell Physiol. 232:1030–1040. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu YJ, Liu RY, Hu K and Wang Y: MiR-541-3p
reverses cancer progression by directly targeting TGIF2 in
non-small cell lung cancer. Tumour Biol. 37:12685–12695. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Guo Y, Wang C and Yu H, Yu X and
Yu H: MicroRNA-142-3p inhibits chondrocyte apoptosis and
inflammation in osteoarthritis by targeting HMGB1. Inflammation.
39:1718–1728. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu B, Ding JF, Luo J, Lu L, Yang F and
Tan XD: Seven protective miRNA signatures for prognosis of cervical
cancer. Oncotarget. 7:56690–56698. 2016.PubMed/NCBI
|
|
16
|
Chang TY, Tsai WC, Huang TS, Su SH, Chang
CY, Ma HY, Wu CH, Yang CY, Lin CH, Huang PH, et al: Dysregulation
of endothelial colony-forming cell function by a negative feedback
loop of circulating miR-146a and −146b in cardiovascular disease
patients. PLoS One. 12:e01815622017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carr G, Barrese V, Stott JB, Povstyan OV,
Jepps TA, Figueiredo HB, Zheng D, Jamshidi Y and Greenwood IA:
MicroRNA-153 targeting of KCNQ4 contributes to vascular dysfunction
in hypertension. Cardiovasc Res. pii:cvw1772016.
|
|
18
|
Oury C, Servais L, Bouznad N, Hego A,
Nchimi A and Lancellotti P: MicroRNAs in valvular heart diseases:
Potential role as markers and actors of valvular and cardiac
remodeling. Int J Mol Sci. 17:pii: E11202016. View Article : Google Scholar
|
|
19
|
Elia L and Condorelli G: MicroRNAs and
pulmonary hypertension: A tight link. Cardiovasc Res. 111:163–164.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu L, Yu H, Li X, Jin C, Zhao Y, Xu S and
Sheng X: P38 MAPK/miR-1 are involved in the protective effect of
EGCG in high glucose-induced Cx43 downregulation in neonatal rat
cardiomyocytes. Cell Biol Int. 40:934–942. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tong JL, Zhang CP, Nie F, Xu XT, Zhu MM,
Xiao SD and Ran ZH: MicroRNA 506 regulates expression of PPAR alpha
in hydroxycamptothecin-resistant human colon cancer cells. FEBS
Lett. 585:3560–3568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng T, Zhou L, Zuo L and Luan Y: MiR-506
functions as a tumor suppressor in glioma by targeting STAT3. Oncol
Rep. 35:1057–1064. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Liu Z, Dong S, Zhang J, Tan J, Wang
Y, Ge C, Li R, Xue Y, Li M, et al: miR-506 inhibits
epithelial-to-mesenchymal transition and angiogenesis in gastric
cancer. Am J Pathol. 185:2412–2420. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen C, Yang S, Li H, Yin Z, Fan J, Zhao
Y, Gong W, Yan M and Wang DW: Mir30c is involved in diabetic
cardiomyopathy through regulation of cardiac autophagy via BECN1.
Mol Ther Nucleic Acids. 7:127–139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Al-Shenawy HA: Expression of Beclin-1, an
autophagy-related marker, in chronic hepatitis and hepatocellular
carcinoma and its relation with apoptotic markers. APMIS.
124:229–237. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, Wang Y, Qian L, Wang X, Gu H, Dong
X, Huang S, Jin M, Ge H, Xu C and Zhang Y: RNF216 contributes to
proliferation and migration of colorectal cancer via suppressing
BECN1-dependent autophagy. Oncotarget. 7:51174–51183.
2016.PubMed/NCBI
|
|
27
|
Liu LS: Writing Group of 2010 Chinese
Guidelines for the Management of Hypertension: 2010 Chinese
guidelines for the management of hypertension. Zhonghua Xin Xue
Guan Bing Za Zhi. 39:579–615. 2011.(In Chinese). PubMed/NCBI
|
|
28
|
Nwokeoji AO, Kilby PM, Portwood DE and
Dickman MJ: RNASwift: A rapid, versatile RNA extraction method free
from phenol and chloroform. Anal Biochem. 512:36–46. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vashukova ES, Glotov AS, Fedotov PV,
Efimova OA, Pakin VS, Mozgovaya EV, Pendina AA, Tikhonov AV,
Koltsova AS and Baranov VS: Placental microRNA expression in
pregnancies complicated by superimposed pre-eclampsia on chronic
hypertension. Mol Med Rep. 14:22–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Klimczak D, Jazdzewski K and Kuch M:
Regulatory mechanisms in arterial hypertension: Role of microRNA in
pathophysiology and therapy. Blood Press. 26:2–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Potus F, Graydon C, Provencher S and
Bonnet S: Vascular remodeling process in pulmonary arterial
hypertension, with focus on miR-204 and miR-126 (2013 Grover
Conference series). Pulm Circ. 4:175–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ruffenach G, Chabot S, Tanguay VF,
Courboulin A, Boucherat O, Potus F, Meloche J, Pflieger A,
Breuils-Bonnet S, Nadeau V, et al: Role for runt-related
transcription factor 2 in proliferative and calcified vascular
lesions in pulmonary arterial hypertension. Am J Respir Crit Care
Med. 194:1273–1285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang LX, Liu G, Zhu GF, Liu H, Guo RW, Qi
F and Zou JH: MicroRNA-155 inhibits angiotensin II-induced vascular
smooth muscle cell proliferation. J Renin Angiotensin Aldosterone
Syst. 15:109–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kamo Y, Ichikawa T, Miyaaki H, Uchida S,
Yamaguchi T, Shibata H, Honda T, Taura N, Isomoto H, Takeshima F
and Nakao K: Significance of miRNA-122 in chronic hepatitis C
patients with serotype 1 on interferon therapy. Hepatol Res.
45:88–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoruk A, Bisognano JD and Gassler JP:
Baroreceptor stimulation for resistant hypertension. Am J
Hypertens. 29:1319–1324. 2016.PubMed/NCBI
|
|
37
|
Wang MM, Fang MX, Chen LG, Wang HQ, Liu HJ
and Tang HL: Differential expression of microRNA in endothelial
cells incubated with serum of hypertension patients with
blood-stasis syndrome. Chin J Integr Med. 21:817–822. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kumar A, Singh UK and Chaudhary A:
Targeting autophagy to overcome drug resistance in cancer therapy.
Future Med Chem. 7:1535–1542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang X, Tao Y, Huang Y, Zhan K, Xue M,
Wang Y, Ruan D, Liang Y, Huang X, Lin J, et al: Catalase
ameliorates diabetes-induced cardiac injury through reduced
p65/RelA-mediated transcription of BECN1. J Cell Mol Med. Jun
23–2017.(Epub ahead of print).
|
|
40
|
Mizuno S, Bogaard HJ, Gomez-Arroyo J,
Alhussaini A, Kraskauskas D, Cool CD and Voelkel NF:
MicroRNA-199a-5p is associated with hypoxia-inducible factor-1a
expression in lungs from patients with COPD. Chest. 142:663–672.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Goyal A, Gubbiotti MA, Chery DR, Han L and
Iozzo RV: Endorepellin-evoked autophagy contributes to angiostasis.
J Biol Chem. 291:19245–19256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qi JJ, Han XF, Cai XL, Li XZ, Zhang LQ,
Feng X and Liu DY: Expression and clinical significance of
autophagy-related gene Beclin1 and P62 in nasal polyps. Zhonghua Er
Bi Yan Hou Tou Jing Wai Ke Za Zhi. 51:428–432. 2016.(In Chinese).
PubMed/NCBI
|
|
43
|
Baek JH, Jung J, Seo J, Kim JH and Kim J:
Bacterial overexpression and denaturing purification of
VPS34-binding domain of Beclin 1. J Microbiol Biotechnol.
26:1808–1816. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Y, Jiang W, Hu Y, Da Z, Zeng C, Tu M,
Deng Z and Xiao W: MicroRNA-199a-5p inhibits cisplatin-induced drug
resistance via inhibition of autophagy in osteosarcoma cells. Oncol
Lett. 12:4203–4208. 2016. View Article : Google Scholar : PubMed/NCBI
|
